BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

7411 related articles for article (PubMed ID: 23945592)

  • 21. DNA deaminases induce break-associated mutation showers with implication of APOBEC3B and 3A in breast cancer kataegis.
    Taylor BJ; Nik-Zainal S; Wu YL; Stebbings LA; Raine K; Campbell PJ; Rada C; Stratton MR; Neuberger MS
    Elife; 2013 Apr; 2():e00534. PubMed ID: 23599896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. APOBEC mutagenesis, kataegis, chromothripsis in EGFR-mutant osimertinib-resistant lung adenocarcinomas.
    Selenica P; Marra A; Choudhury NJ; Gazzo A; Falcon CJ; Patel J; Pei X; Zhu Y; Ng CKY; Curry M; Heller G; Zhang YK; Berger MF; Ladanyi M; Rudin CM; Chandarlapaty S; Lovly CM; Reis-Filho JS; Yu HA
    Ann Oncol; 2022 Dec; 33(12):1284-1295. PubMed ID: 36089134
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unravelling the Sequential Interplay of Mutational Mechanisms during Clonal Evolution in Relapsed Pediatric Acute Lymphoblastic Leukemia.
    Antić Ž; Lelieveld SH; van der Ham CG; Sonneveld E; Hoogerbrugge PM; Kuiper RP
    Genes (Basel); 2021 Feb; 12(2):. PubMed ID: 33540666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA mismatch repair promotes APOBEC3-mediated diffuse hypermutation in human cancers.
    Mas-Ponte D; Supek F
    Nat Genet; 2020 Sep; 52(9):958-968. PubMed ID: 32747826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospectively defined patterns of APOBEC3A mutagenesis are prevalent in human cancers.
    DeWeerd RA; Németh E; Póti Á; Petryk N; Chen CL; Hyrien O; Szüts D; Green AM
    Cell Rep; 2022 Mar; 38(12):110555. PubMed ID: 35320711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. APOBEC-Induced Mutagenesis in Cancer.
    Mertz TM; Collins CD; Dennis M; Coxon M; Roberts SA
    Annu Rev Genet; 2022 Nov; 56():229-252. PubMed ID: 36028227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A framework for mutational signature analysis based on DNA shape parameters.
    Karolak A; Levatić J; Supek F
    PLoS One; 2022; 17(1):e0262495. PubMed ID: 35015788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The landscape of cancer genes and mutational processes in breast cancer.
    Stephens PJ; Tarpey PS; Davies H; Van Loo P; Greenman C; Wedge DC; Nik-Zainal S; Martin S; Varela I; Bignell GR; Yates LR; Papaemmanuil E; Beare D; Butler A; Cheverton A; Gamble J; Hinton J; Jia M; Jayakumar A; Jones D; Latimer C; Lau KW; McLaren S; McBride DJ; Menzies A; Mudie L; Raine K; Rad R; Chapman MS; Teague J; Easton D; Langerød A; ; Lee MT; Shen CY; Tee BT; Huimin BW; Broeks A; Vargas AC; Turashvili G; Martens J; Fatima A; Miron P; Chin SF; Thomas G; Boyault S; Mariani O; Lakhani SR; van de Vijver M; van 't Veer L; Foekens J; Desmedt C; Sotiriou C; Tutt A; Caldas C; Reis-Filho JS; Aparicio SA; Salomon AV; Børresen-Dale AL; Richardson AL; Campbell PJ; Futreal PA; Stratton MR
    Nature; 2012 May; 486(7403):400-4. PubMed ID: 22722201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Network-based approaches elucidate differences within APOBEC and clock-like signatures in breast cancer.
    Kim YA; Wojtowicz D; Sarto Basso R; Sason I; Robinson W; Hochbaum DS; Leiserson MDM; Sharan R; Vadin F; Przytycka TM
    Genome Med; 2020 May; 12(1):52. PubMed ID: 32471470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of APOBEC3 mutagenesis in human cancer cells.
    Petljak M; Dananberg A; Chu K; Bergstrom EN; Striepen J; von Morgen P; Chen Y; Shah H; Sale JE; Alexandrov LB; Stratton MR; Maciejowski J
    Nature; 2022 Jul; 607(7920):799-807. PubMed ID: 35859169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exploring the implications of distinct mutational signatures and mutation rates in aging and cancer.
    Fox EJ; Salk JJ; Loeb LA
    Genome Med; 2016 Mar; 8(1):30. PubMed ID: 26987311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recurrent somatic mutations reveal new insights into consequences of mutagenic processes in cancer.
    Stobbe MD; Thun GA; Diéguez-Docampo A; Oliva M; Whalley JP; Raineri E; Gut IG
    PLoS Comput Biol; 2019 Nov; 15(11):e1007496. PubMed ID: 31765368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular origins of APOBEC-associated mutations in cancer.
    Petljak M; Maciejowski J
    DNA Repair (Amst); 2020 Oct; 94():102905. PubMed ID: 32818816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutational processes of tobacco smoking and APOBEC activity generate protein-truncating mutations in cancer genomes.
    Adler N; Bahcheli AT; Cheng KCL; Al-Zahrani KN; Slobodyanyuk M; Pellegrina D; Schramek D; Reimand J
    Sci Adv; 2023 Nov; 9(44):eadh3083. PubMed ID: 37922356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Addressing the benefits of inhibiting APOBEC3-dependent mutagenesis in cancer.
    Petljak M; Green AM; Maciejowski J; Weitzman MD
    Nat Genet; 2022 Nov; 54(11):1599-1608. PubMed ID: 36280735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of Mutational Signatures Using the mutSignatures R Library.
    Fantini D; Meeks JJ
    Methods Mol Biol; 2023; 2684():45-57. PubMed ID: 37410227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Error-free versus mutagenic processing of genomic uracil--relevance to cancer.
    Krokan HE; Sætrom P; Aas PA; Pettersen HS; Kavli B; Slupphaug G
    DNA Repair (Amst); 2014 Jul; 19():38-47. PubMed ID: 24746924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Somatic mutational signatures in polyposis and colorectal cancer.
    Grolleman JE; Díaz-Gay M; Franch-Expósito S; Castellví-Bel S; de Voer RM
    Mol Aspects Med; 2019 Oct; 69():62-72. PubMed ID: 31108140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of mutation signature effectuating processes with mutation hotspots in driver genes and non-coding regions.
    Wong JKL; Aichmüller C; Schulze M; Hlevnjak M; Elgaafary S; Lichter P; Zapatka M
    Nat Commun; 2022 Jan; 13(1):178. PubMed ID: 35013316
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutational signatures reveal ternary relationships between homologous recombination repair, APOBEC, and mismatch repair in gynecological cancers.
    Farmanbar A; Firouzi S; Kneller R; Khiabanian H
    J Transl Med; 2022 Feb; 20(1):65. PubMed ID: 35109853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 371.